Table 4.

IC₅₀ (µM) concentration of thornasteroside A (structure shown in Table 3) cytotoxicity tests.

Cell Line	Cell Type Description	Concentration (µM)	Cell Viability Method	Incubation Period (h)	Reference
BEL-7402	human hepatoma	7.39 *	SRB	48	[8]
K-562	human leukaemia	10.61 *	MTT	48	[8]
MDA-MB-231	human breast	28.00	MTS	24	[40]
HT-29	human colorectal carcinoma	32.00	MTS	24	[40]
JB6 CI41	non-cancerous mouse epidermal	34.00	MTS	24	[40]
THP-1	human monocytic leukaemia	39.00	MTS	24	[40]
Raji	human Burkitt’s lymphoma	48.00	MTS	24	[40]
RPMI-7951	human melanoma	50.00	MTS	24	[41]
HCT-116	human colorectal carcinoma	82.00	MTS	24	[41]
T-47D	human breast	94.00	MTS	24	[41]

* Note: converted units from µg/mL.